MGNX Achieves $10 Million Milestone
MGNX achieves $10 million milestone after Gilead exercises option to license preclinical bispecific program
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
MGNX achieves $10 million milestone after Gilead exercises option to license preclinical bispecific program